In 2016 the WHO classification of CNS tumors included another BRAF-associated glial tumor, the diffuse leptomeningeal glioneuronal tumor (DLGT), as a molecularly defined entity of BRAF-associated neoplasm. This evidence concerns the gene BRAF and glioma.